EGFR and non-small cell lung carcinoma: For instance, the Google Health team (2022) (112) proposed the “Med-PaLM” model, which fine-tunes LLMs (e.g., GPT-3) to integrate pathology reports with radiomics data, achieving an AUC of 0.89(NR) in NSCLC EGFR mutation prediction, significantly outperforming conventional methods.